COMPANY
Mestag Therapeutics Limited
Raises and deals from press releases
- Raise Undisclosed round · $40M · announced Mar 17, 2026 Company release ↗
Source quote
- Mar 17, 2026 · Company release ↗
“Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic”
- Mar 17, 2026 · Company release ↗
- Deal MSD deal · amount not disclosed · announced Oct 8, 2024 Company release ↗
Source quote
- Oct 8, 2024 · Company release ↗
“– Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has entered into a license and collaboration agreement with MSD (tradename of Merck & Co.”
- Oct 8, 2024 · Company release ↗